Risk and Protective Factors in Multimodal Pain Therapy in Patients With Chronic Lumbal Pain
1 other identifier
observational
200
1 country
1
Brief Summary
Results will show important information about potential protective factors which might be relevant for the recovery of patients suffering from low back pain (theoretical basis). On a clinically applied basis we plan the validation of a short screening in concerns of psychosocial risk and protective factors in patients with chronic low back pain undergoing a multimodal pain therapy (MPT), and this for the first time. Three main aims are: 1. Prospective validation of a short screening on a theoretical basis for the collection of psychosocial risk factors concerning of an unfavourable therapeutic process in MPT. 2. the verification of differences in subgroups with regard to pain management on a basis of the Avoidance Endurance Model in the development of pain and pain-related disability. 3. The evaluation of potential psychosocial protective factors supporting a positive outcome of MPT, such as resilience, acceptance, self-compassion, and body image.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2021
CompletedFirst Posted
Study publicly available on registry
May 11, 2021
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMay 18, 2022
May 1, 2022
11 months
April 30, 2021
May 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Chronic Pain Score (von Korff)
change of pain intensity from baseline to 3-months-follow up (three time points); minimum value 0 (no pain), maximum value 10 (worst pain possible), higher scores mean a worse outcome
15 weeks
Chronic Disability Score (von Korff)
change of pain-related disability from baseline to 3-months-follow up (three time points); minimum value 0 (no disability), maximum value 10 (worst disability possible), higher scores mean a worse outcome
15 weeks
Secondary Outcomes (5)
Resilience Scale-13 (RS-13)
first day of study participation
Chronic Pain Acceptance Questionnaire (CPAQ)
first day of study participation
Self-compassion Scale (SCS)
first day of study participation
Frankfurter Körperkonzeptskalen (FKKS, Frankfurt Body Concept Scales)
15 weeks
Fremantle Back Awareness Questionnaire (FreBAQ)
15 weeks
Study Arms (1)
Patients with chronic low back pain
Patients suffering from chronic low back pain (duration longer than 3 months) undergoing a multimodal pain therapy
Interventions
Patients with chronic low back pain in in-patient multimodal pain therapy. Three survey times, questionnaires
Eligibility Criteria
in-patients pain clinic
You may qualify if:
- chronic low back pain
You may not qualify if:
- acute inflammatory diseases
- acute fractures
- pregnancy
- neurological dieases
- psychiatric diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruhr University of Bochumlead
- Katholisches Klinikum Bochumcollaborator
Study Sites (1)
Katholisches Klinikum, Klinik Blankenstein
Hattingen, 45527, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Tobias L Schulte, Prof.
Katholisches Klinikum Bochum
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
April 30, 2021
First Posted
May 11, 2021
Study Start
January 1, 2023
Primary Completion
December 1, 2023
Study Completion
December 1, 2024
Last Updated
May 18, 2022
Record last verified: 2022-05